company background image
538965 logo

Concord Drugs BSE:538965 Stock Report

Last Price

₹35.17

Market Cap

₹351.7m

7D

-0.2%

1Y

30.6%

Updated

28 Mar, 2024

Data

Company Financials

Concord Drugs Limited

BSE:538965 Stock Report

Market Cap: ₹351.7m

Concord Drugs Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Concord Drugs
Historical stock prices
Current Share Price₹35.17
52 Week High₹61.50
52 Week Low₹25.56
Beta0.37
1 Month Change-11.07%
3 Month Change-41.11%
1 Year Change30.65%
3 Year Change15.31%
5 Year Change61.33%
Change since IPO75.94%

Recent News & Updates

Recent updates

Shareholder Returns

538965IN PharmaceuticalsIN Market
7D-0.2%2.7%2.5%
1Y30.6%63.9%47.3%

Return vs Industry: 538965 underperformed the Indian Pharmaceuticals industry which returned 63.9% over the past year.

Return vs Market: 538965 underperformed the Indian Market which returned 47.3% over the past year.

Price Volatility

Is 538965's price volatile compared to industry and market?
538965 volatility
538965 Average Weekly Movement7.4%
Pharmaceuticals Industry Average Movement5.9%
Market Average Movement6.6%
10% most volatile stocks in IN Market10.1%
10% least volatile stocks in IN Market4.0%

Stable Share Price: 538965's share price has been volatile over the past 3 months.

Volatility Over Time: 538965's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1995185Seelam Reddyhttps://www.concorddrugs.in

Concord Drugs Limited manufactures and sells pharmaceutical formulations in India. It offers drugs in the form of tablets, capsules, small volume parenterals, dry powders, dry syrups, and liquid orals, as well as ready-to-fill pellets and multiple unit pellets system. The company was incorporated in 1995 and is based in Hyderabad, India.

Concord Drugs Limited Fundamentals Summary

How do Concord Drugs's earnings and revenue compare to its market cap?
538965 fundamental statistics
Market cap₹351.70m
Earnings (TTM)₹9.74m
Revenue (TTM)₹415.89m

36.1x

P/E Ratio

0.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
538965 income statement (TTM)
Revenue₹415.89m
Cost of Revenue₹313.76m
Gross Profit₹102.13m
Other Expenses₹92.39m
Earnings₹9.74m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 30, 2024

Earnings per share (EPS)0.97
Gross Margin24.56%
Net Profit Margin2.34%
Debt/Equity Ratio52.3%

How did 538965 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.